SHG.AU Singular Health Group Ltd
- Market cap
- AUD 58.7M
- P/E
- -
- P/B
- 5.57x
- ROE
- -127.9%
- Dividend yield
- -
- Fundamental score
- 2.0/5
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is SHG.AU undervalued?
Graham numberThe Graham number of Singular Health Group Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Singular Health Group Ltd fundamental analysis
9 of 21 checks passedROE 0/2
Low return on equity (-127.9%), below 10%.
ROA 0/1
Return on assets (-120.0%) is below the industry median (-45.6%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 1/1
Last year's EPS growth (24.6%) is above the industry median (18.9%).
Revenue Growth 2/2
Revenue grew 270.3% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (1.0%), 40% or less.
Debt Trend 1/1
Debt to equity has not risen over the past 5 years.
Cash Runway 1/2
Cash covers 1.1 years of the current cash burn.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 1/1
Price to book (5.6x) is below the industry median (5.7x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Singular Health Group Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Singular Health Group Ltd
Singular Health Group Ltd, operates as a healthcare technology company in Australia. The company Volumetric Rendering Platform, a proprietary technology that enhances the visualization of patient anatomy and health issues by converting 2D images from CT, MRI, and PET scans into 3D models. It also provides Medical File Transfer Protocol, a technology that streamlines the access, sharing, and storage of medical images, such as CT, MRI, and PET scans across electronic devices a…
Full company profileSingular Health Group Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Singular Health Group Ltd annual financial statements
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 104K | 194K | 54.0K | 28.1K | 934K | 558K | 1.43M | 3.80M |
| Gross Profit | -669K | -1.62M | -2.11M | -3.58M | 516K | -86.2K | -4.02M | -7.45M |
| Operating Income | -669K | -2.90M | -6.25M | -4.77M | -2.86M | -6.20M | -6.77M | -12.3M |
| EBITDA | -621K | -2.86M | -5.65M | -4.52M | -2.58M | -6.27M | -6.69M | -12.1M |
| Net Income | -708K | -4.46M | -5.99M | -5.39M | -4.92M | -6.38M | -6.34M | -13.5M |
| EPS | -0.01 | -0.04 | -0.06 | -0.05 | -0.03 | -0.03 | -0.02 | -0.04 |
| Balance Sheet | ||||||||
| Total Assets | 668K | 5.43M | 2.14M | 3.00M | 2.35M | 14.2M | 11.2M | 11.2M |
| Total Liabilities | 882K | 345K | 392K | 2.94M | 910K | 1.11M | 699K | 699K |
| Shareholders' Equity | -214K | 5.08M | 1.75M | 61.9K | 1.44M | 13.1M | 10.5M | 10.5M |
| Cash & Short-term Investments | 131K | 4.14M | 1.14M | 692K | 1.45M | 13.7M | 10.1M | 10.1M |
| Total Debt | 746K | 148K | 85.7K | 2.51M | 218K | - | 110K | 110K |
| Cash Flow | ||||||||
| Operating Cash Flow | -548K | -1.91M | -2.91M | -2.46M | -2.44M | -2.34M | -5.30M | -8.77M |
| Capital Expenditure | 259K | 311K | 11.8K | 22.5K | 73.6K | 29.2K | 144K | 117K |
| Free Cash Flow | -807K | -2.22M | -2.92M | -2.49M | -2.51M | -2.37M | -5.45M | -8.88M |
| Ratios | ||||||||
| ROE | - | -87.7% | -342.3% | -8,709.2% | -341.7% | -48.7% | -60.2% | -127.9% |
| ROA | -105.9% | -82.1% | -279.7% | -179.8% | -209.5% | -44.9% | -56.4% | -120.0% |
| Net Profit Margin | -681.3% | -2,301.2% | -11,078.2% | -19,167.6% | -527.2% | -1,143.5% | -443.9% | -355.2% |
| Debt to Equity | - | 0.03x | 0.05x | 40.56x | 0.15x | - | 0.01x | 0.01x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Singular Health Group Ltd dividends
Singular Health Group Ltd has not paid dividends in the last 7 fiscal years.
Who owns Singular Health Group Ltd
- Insiders 31.39%
- Institutions 1.54%
- Public & others 67.07%
- Shares outstanding 326M
- Free float 227M
Singular Health Group Ltd company profile
- Company name
- Singular Health Group Ltd
- Ticker
- SHG.AU
- ISIN
- AU0000129892
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Health Care Technology
- Fiscal year end
- December
- Address
- E3/661 Newcastle Stree, Leederville, WA, Australia, 6007
- Phone
- 61 1300 167 795
- Website
- singular.health
About Singular Health Group Ltd
Singular Health Group Ltd, operates as a healthcare technology company in Australia. The company Volumetric Rendering Platform, a proprietary technology that enhances the visualization of patient anatomy and health issues by converting 2D images from CT, MRI, and PET scans into 3D models. It also provides Medical File Transfer Protocol, a technology that streamlines the access, sharing, and storage of medical images, such as CT, MRI, and PET scans across electronic devices and healthcare providers. In addition, the company offers AI in the Cloud that enhances medical imaging by integrating AI models. Further, it provides 3DICOM MD for healthcare professionals; 3DICOM EDU and XR for academics and researchers; and 3DICOM Patient for patients. Additionally, the company is involved in development and commercialization of the 3DICOM platform; enterprise healthcare imaging/interoperability solutions; education applications; and associated regulatory and product-development activities. Singular Health Group Ltd was incorporated in 2020 and is based in Leederville, Australia.
Singular Health Group Ltd management
5- Mr. Denning ChongCo-Founder, MD, CEO & Executive Director
- Dr. Martina MarianoChief Operating Officer
- Ms. Paige TaylorChief Commercial Officer
- Ms. Kyla Garic B.Com., C.A.Chief Financial Officer
- Mr. Steven Douglas Wood B.Com., C.A.Company Secretary